Literature DB >> 1995597

Lessons to be learned from long-term treatment of affective disorders: potential utility in panic disorder.

D J Kupfer1.   

Abstract

Although the research on long-term treatment for panic disorder is in an early stage, there is a considerable body of data on affective disorders. The author discusses three long-term projects pertinent to affective disorders, with the idea that they may suggest possible avenues of research in the field of panic disorder: (1) the MacArthur Foundation task force arrives at consensus definitions and proposes tentative operational criteria; (2) the National Institute of Mental Health Collaborative Study compares the effects of lithium carbonate, imipramine, the lithium/imipramine combination, and placebo in preventing the recurrence of affective disorders; and (3) the Pittsburgh Study explores the efficacy of the combination of imipramine and interpersonal psychotherapy as a preventive strategy against recurrence of depression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1995597

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  3 in total

1.  Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine.

Authors:  A Szegedi; R Kohnen; A Dienel; M Kieser
Journal:  BMJ       Date:  2005-02-11

2.  Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after successful acute treatment of mild to moderate depression--rationale and study design.

Authors:  S Kasper; A Dienel; M Kieser
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

3.  Placebo controlled continuation treatment with Hypericum extract WS 5570 after recovery from a mild or moderate depressive episode.

Authors:  Siegfried Kasper; Ion-Gheorge Anghelescu; Armin Szegedi; Angelika Dienel; Meinhard Kieser
Journal:  Wien Med Wochenschr       Date:  2007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.